AMPK-dependent metabolic regulation by PPAR agonists

PPAR Research

Volumn , Issue , 2010, Pages

  Kim, Sang Geon ^a   Lee, Woo Hyung ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

DRUG EFFECT; ENZYME ACTIVITY; ENZYME METABOLISM; HUMAN; METABOLIC REGULATION; REVIEW;

EID: 77956842224     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/549101     Document Type: Review

References (72)

1. Ahmed W., Ziouzenkova O., Brown J., Devchand P., Francis S., Kadakia M., Kanda T., Orasanu G., Sharlach M., Zandbergen F., Plutzky J., PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? Journal of Internal Medicine 2007 262 2 184 198
2. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650
3. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W., Control of the peroxisomal -oxidation pathway by a novel family of nuclear hormone receptors Cell 1992 68 5 879 887
4. Diradourian C., Girard J., Pgorier J.-P., Phosphorylation of PPARs: from molecular characterization to physiological relevance Biochimie 2005 87 1 33 38
5. Chanda D., Lee C. H., Kim Y.-H., Noh J.-R., Kim D.-K., Park J.-H., Hwang J. H., Lee M.-R., Jeong K.-H., Lee I.-K., Kweon G. R., Shong M., Oh G.-T., Chiang J. Y. L., Choi H.-S., Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner Hepatology 2009 50 3 880 892
6. Liangpunsakul S., Wou S.-E., Wineinger K. D., Zeng Y., Cyganek I., Jayaram H. N., Crabb D. W., Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase Archives of Biochemistry and Biophysics 2009 485 1 10 15
7. Fryer L. G. D., Parbu-Patel A., Carling D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways Journal of Biological Chemistry 2002 277 28 25226 25232
8. Saha A. K., Avilucea P. R., Ye J.-M., Assifi M. M., Kraegen E. W., Ruderman N. B., Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo Biochemical and Biophysical Research Communications 2004 314 2 580 585
9. LeBrasseur N. K., Kelly M., Tsao T.-S., Farmer S. R., Saha A. K., Ruderman N. B., Tomas E., Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues American Journal of PhysiologyEndocrinology and Metabolism 2006 291 1 E175 E181
10. Zoete V., Grosdidier A., Michielin O., Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators Biochimica et Biophysica Acta 2007 1771 8 915 925
11. Giann M., Tarrade A., Nigro E. A., Garattini E., Rochette-Egly C., The AF-1 and AF-2 domains of RAR 2 and RXR cooperate for triggering the transactivation and the degradation of RAR 2/RXR heterodimers Journal of Biological Chemistry 2003 278 36 34458 34466
12. Yoon M., The role of PPAR in lipid metabolism and obesity: focusing on the effects of estrogen on PPAR actions Pharmacological Research 2009 60 3 151 159
13. Costet P., Legendre C., Mor J., Edgar A., Galtier P., Pineau T., Peroxisome proliferator-activated receptor -isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis Journal of Biological Chemistry 1998 273 45 29577 29585
14. Barber M. J., Schlter A., Pedraza N., Iglesias R., Villarroya F., Giralt M., Peroxisome proliferator-activated receptor activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell Journal of Biological Chemistry 2001 276 2 1486 1493
15. Nakatani T., Tsuboyama-Kasaoka N., Takahashi M., Miura S., Ezaki O., Mechanism for peroxisome proliferator-activated receptor- activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes Journal of Biological Chemistry 2002 277 11 9562 9569
16. Brun S., Carmona M. C., Mampel T., Vias O., Giralt M., Iglesias R., Villarroya F., Activators of peroxisome proliferator-activated receptor- induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth Diabetes 1999 48 6 1217 1222
17. Barish G. D., Narkar V. A., Evans R. M., PPAR : a dagger in the heart of the metabolic syndrome Journal of Clinical Investigation 2006 116 3 590 597
18. Evans R. M., Barish G. D., Wang Y.-X., PPARs and the complex journey to obesity Nature Medicine 2004 10 4 355 361
19. Johnson T. E., Holloway M. K., Vogel R., Rutledge S. J., Perkins J. J., Rodan G. A., Schmidt A., Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors Journal of Steroid Biochemistry and Molecular Biology 1997 63 13 1 8
20. Wang Y.-X., Lee C.-H., Tiep S., Yu R. T., Ham J., Kang H., Evans R. M., Peroxisome-proliferator-activated receptor activates fat metabolism to prevent obesity Cell 2003 113 2 159 170
21. Chawla A., Lee C.-H., Barak Y., He W., Rosenfeld J., Liao D., Han J., Kang H., Evans R. M., PPAR is a very low-density lipoprotein sensor in macrophages Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 1268 1273
22. Wang Y.-X., Zhang C.-L., Yu R. T., Cho H. K., Nelson M. C., Bayuga-Ocampo C. R., Ham J., Kang H., Evans R. M., Regulation of muscle fiber type and running endurance by PPAR PLoS Biology 2004 2 10, article e294
23. Narkar V. A., Downes M., Yu R. T., Embler E., Wang Y.-X., Banayo E., Mihaylova M. M., Nelson M. C., Zou Y., Juguilon H., Kang H., Shaw R. J., Evans R. M., AMPK and PPAR agonists are exercise mimetics Cell 2008 134 3 405 415
24. Chawla A., Boisvert W. A., Lee C.-H., Laffitte B. A., Barak Y., Joseph S. B., Liao D., Nagy L., Edwards P. A., Curtiss L. K., Evans R. M., Tontonoz P., A PPAR -LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Molecular Cell 2001 7 1 161 171
25. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., Satoh S., Nakano R., Ish C. II, Sugiyama T., Kazuhiro E., Tsubamoto Y., Okuno A., Murakami K., Sekihara H., Hasegawa G., Naito M., Toyoshima Y., Tanaka S., Shiota K., Kitamura T., Fujita T., Ezaki O., Aizawa S., Nagai R., Tobe K., Kimura S., Kadowaki T., PPAR mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance Molecular Cell 1999 4 4 597 609
26. Sugii S., Olson P., Sears D. D., Saberi M., Atkins A. R., Barish G. D., Hong S.-H., Castro G. L., Yin Y.-Q., Nelson M. C., Hsiao G., Greaves D. R., Downes M., Yu R. T., Olefsky J. M., Evans R. M., PPAR activation in adipocytes is sufficient for systemic insulin sensitization Proceedings of the National Academy of Sciences of the United States of America 2009 106 52 22504 22509
27. Jiang J.-G., Johnson C., Zarnegar R., Peroxisome proliferator-activated receptor -mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element Journal of Biological Chemistry 2001 276 27 25049 25056
28. Han J., Hajjar D. P., Zhou X., Gotto A. M. Jr., Nicholson A. C., Regulation of peroxisome proliferator-activated receptor- -mediated gene expression a new mechanism of action for high density lipoprotein Journal of Biological Chemistry 2002 277 26 23582 23586
29. Coletta D. K., Sriwijitkamol A., Wajcberg E., Tantiwong P., Li M., Prentki M., Madiraju M., Jenkinson C. P., Cersosimo E., Musi N., DeFronzo R. A., Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial Diabetologia 2009 52 4 723 732
30. Towler M. C., Hardie D. G., AMP-activated protein kinase in metabolic control and insulin signaling Circulation Research 2007 100 3 328 341
31. Lage R., Diguez C., Vidal-Puig A., Lpez M., AMPK: a metabolic gauge regulating whole-body energy homeostasis Trends in Molecular Medicine 2008 14 12 539 549
32. Woods A., Johnstone S. R., Dickerson K., Leiper F. C., Fryer L. G. D., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D., LKB1 is the upstream kinase in the AMP-activated protein kinase cascade Current Biology 2003 13 22 2004 2008 (Pubitemid 37425212)
33. Hawley S. A., Pan D. A., Mustard K. J., Ross L., Bain J., Edelman A. M., Frenguelli B. G., Hardie D. G., Calmodulin-dependent protein kinase kinase- is an alternative upstream kinase for AMP-activated protein kinase Cell Metabolism 2005 2 1 9 19
34. Momcilovic M., Hong S.-P., Carlson M., Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro Journal of Biological Chemistry 2006 281 35 25336 25343
35. Alessi D. R., Sakamoto K., Bayascas J. R., LKB1-dependent signaling pathways Annual Review of Biochemistry 2006 75 137 163
36. Xie Z., Dong Y., Scholz R., Neumann D., Zou M.-H., Phosphorylation of LKB1 at serine 428 by protein kinase C- is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells Circulation 2008 117 7 952 962
37. Hurley R. L., Anderson K. A., Franzone J. M., Kemp B. E., Means A. R., Witters L. A., The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases Journal of Biological Chemistry 2005 280 32 29060 29066
38. Bugianesi E., McCullough A. J., Marchesini G., Insulin resistance: a metabolic pathway to chronic liver disease Hepatology 2005 42 5 987 1000
39. Inoki K., Zhu T., Guan K.-L., TSC2 mediates cellular energy response to control cell growth and survival Cell 2003 115 5 577 590
40. Park S.-S., Zhao H., Mueller R. A., Xu Z., Bradykinin prevents reperfusion injury bytargeting mitochondrial permeability transition pore through glycogen synthase kinase 3 Journal of Molecular and Cellular Cardiology 2006 40 5 708 716
41. Shin S. M., Cho I. J., Kim S. G., Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3 inhibition downstream of poly(ADP-ribose) polymerase-LKB1 pathway Molecular Pharmacology 2009 76 4 884 895
42. Motoshima H., Goldstein B. J., Igata M., Araki E., AMPK and cell proliferationAMPK as a therapeutic target for atherosclerosis and cancer Journal of Physiology 2006 574 1 63 71
43. Rattan R., Giri S., Singh A. K., Singh I., 5-aminoimidazole-4- carboxamide-1- -D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase Journal of Biological Chemistry 2005 280 47 39582 39593
44. Zhang B. B., Zhou G., Li C., AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metabolism 2009 9 5 407 416
45. Kurth-Kraczek E. J., Hirshman M. F., Goodyear L. J., Winder W. W., 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle Diabetes 1999 48 8 1667 1671
46. Hwahng S. H., Ki S. H., Bae E. J., Kim H. E., Kim S. G., Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones Hepatology 2009 49 6 1913 1925
47. Carling D., Clarke P. R., Zammit V. A., Hardie D. G., Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities European Journal of Biochemistry 1989 186 1-2 129 136
48. Fisslthaler B., Fleming I., Activation and signaling by the AMP-activated protein kinase in endothelial cells Circulation Research 2009 105 2 114 127
49. Nagata D., Hirata Y., The role of AMP-activated protein kinase in the cardiovascular system Hypertension Research 2010 33 1 22 28
50. Gutierrez J., Ballinger S. W., Darley-Usmar V. M., Landar A., Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells Circulation Research 2006 99 9 924 932
51. Choy J. C., Granville D. J., Hunt D. W. C., McManus B. M., Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis Journal of Molecular and Cellular Cardiology 2001 33 9 1673 1690
52. Ceolotto G., Gallo A., Papparella I., Franco L., Murphy E., Iori E., Pagnin E., Fadini G. P., Albiero M., Semplicini A., Avogaro A., Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2627 2633
53. Fujisawa K., Nishikawa T., Kukidome D., Imoto K., Yamashiro T., Motoshima H., Matsumura T., Araki E., TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis Biochemical and Biophysical Research Communications 2009 379 1 43 48
54. Nagata D., Mogi M., Walsh K., AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress Journal of Biological Chemistry 2003 278 33 31000 31006
55. Bogardus C., Lillioja S., Mott D. M., Hollenbeck C., Reaven G., Relationship between degree of obesity and in vivo insulin action in man American journal of physiology 1985 248 3, part 1 E286 E291
56. Okazaki M., Iwasaki Y., Nishiyama M., Taguchi T., Tsugita M., Nakayama S., Kambayashi M., Hashimoto K., Terada Y., PPAR / regulates the human SIRT1 gene transcription via Sp1 Endocrine Journal 2010 57 5 403 413
57. Shen Z., Liang X., Rogers C. Q., Rideout D., You M., Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice American Journal of PhysiologyGastrointestinal and Liver Physiology 2010 298 3 G364 G374
58. Qureshi K., Abrams G. A., Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease World Journal of Gastroenterology 2007 13 26 3540 3553
59. Wang X., Zhou L., Shao L., Qian L., Fu X., Li G., Luo T., Gu Y., Li F., Li J., Zheng S., Luo M., Troglitazone acutely activates AMP-activated protein kinase and inhibits insulin secretion from beta cells Life Sciences 2007 81 2 160 165 (Pubitemid 46929110)
60. Lamontagne J., Pepin., Peyot M.-L., Joly., Ruderman N. B., Poitout V., Madiraju S. R. M., Nolan C. J., Prentki M., Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic -cell at submaximal glucose concentrations Endocrinology 2009 150 8 3465 3474
61. Zhang F., Dey D., Brnstrom R., Forsberg L., Lu M., Zhang Q., Sjholm., BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP- Activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose- Stimulated insulin secretion in a PI3K-dependent manner American Journal of Physiology-Cell Physiology 2009 296 2 C346 C354
62. Chang T.-J., Chen W.-P., Yang C., Lu P.-H., Liang Y.-C., Su M.-J., Lee S.-C., Chuang L.-M., Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the KATP channel and insulin secretion in rats Diabetologia 2009 52 6 1112 1121
63. Ye J.-M., Dzamko N., Hoy A. J., Iglesias M. A., Kemp B., Kraegen E., Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats Diabetes 2006 55 10 2797 2804
64. Xiao X., Su G., Brown S. N., Chen L., Ren J., Zhao P., Peroxisome proliferator-activated receptors and agonists stimulate cardiac glucose uptake via activation of AMP-activated protein kinase Journal of Nutritional Biochemistry 2010 21 7 621 626
65. Dimopoulos N., Watson M., Green C., Hundal H. S., The PPAR agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells FEBS Letters 2007 581 24 4743 4748
66. Ratziu V., Charlotte F., Bernhardt C., Giral P., Halbron M., Lenaour G., Hartmann-Heurtier A., Bruckert E., Poynard T., Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) extension trial Hepatology 2010 51 2 445 453
67. Gastaldelli A., Harrison S. A., Belfort-Aguilar R., Hardies L. J., Balas B., Schenker S., Cusi K., Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis Hepatology 2009 50 4 1087 1093
68. Krishnan J., Suter M., Windak R., Krebs T., Felley A., Montessuit C., Tokarska-Schlattner M., Aasum E., Bogdanova A., Perriard E., Perriard J.-C., Larsen T., Pedrazzini T., Krek W., Activation of a HIF1 -PPAR axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy Cell Metabolism 2009 9 6 512 524
69. Murakami H., Murakami R., Kambe F., Cao X., Takahashi R., Asai T., Hirai T., Numaguchi Y., Okumura K., Seo H., Murohara T., Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC Biochemical and Biophysical Research Communications 2006 341 4 973 978
70. Okayasu T., Tomizawa A., Suzuki K., Manaka K.-I., Hattori Y., PPAR activators upregulate eNOS activity and inhibit cytokine-induced NF- B activation through AMP-activated protein kinase activation Life Sciences 2008 82 15-16 884 891
71. Boyle J. G., Logan P. J., Ewart M.-A., Reihill J. A., Ritchie S. A., Connell J. M. C., Cleland S. J., Salt I. P., Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase Journal of Biological Chemistry 2008 283 17 11210 11217
72. Caldwell S. H., Hespenheide E. E., Redick J. A., Iezzoni J. C., Battle E. H., Sheppard B. L., A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis American Journal of Gastroenterology 2001 96 2 519 525